Redox has received $1 million in follow-on Series B funding from the Intermountain Healthcare Innovation Fund, the company announced recently.
“We are thrilled to welcome the Intermountain Healthcare Innovation Fund as a strategic investor,” Redox CEO Luke Bonney said in a statement. “Intermountain is a leading innovator in healthcare technology and Redox is proud to help continue that legacy.”
According to a release, Redox will work with Intermountain as it adopts digital health solutions that integrate with its electronic health record. The health tech startup also will be included in Intermountain’s upcoming commercialization strategy.
Intermountain Healthcare Innovation Fund is managed by Healthbox and affiliated with Intermountain Healthcare, a health system with 22 hospitals and 1,500 employees.
Redox closes its Series B round with $10 million.